These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30676336)

  • 21. Clinical guides for atypical hemolytic uremic syndrome in Japan.
    Kato H; Nangaku M; Hataya H; Sawai T; Ashida A; Fujimaru R; Hidaka Y; Kaname S; Maruyama S; Yasuda T; Yoshida Y; Ito S; Hattori M; Miyakawa Y; Fujimura Y; Okada H; Kagami S;
    Clin Exp Nephrol; 2016 Aug; 20(4):536-543. PubMed ID: 27422619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
    Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP.
    Cruzado JM; de Córdoba SR; Melilli E; Bestard O; Rama I; Sánchez-Corral P; López-Trascasa M; Navarro I; Torras J; Gomà M; Grinyó JM
    Am J Transplant; 2009 Jun; 9(6):1477-83. PubMed ID: 19459807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations.
    Pabst WL; Neuhaus TJ; Nef S; Bresin E; Zingg-Schenk A; Spartà G
    Pediatr Nephrol; 2013 Jul; 28(7):1141-4. PubMed ID: 23519521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemolytic Uremic Syndrome: A Case Report.
    Gaire S; Shrestha M; Bhattarai CD; Dhungana S; Gyawali S; Bajgain A
    JNMA J Nepal Med Assoc; 2023 May; 61(261):472-474. PubMed ID: 37203902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Incomplete thrombotic microangiopathy as a variant of hemolytic-uremic syndrome].
    Kozlovskaya NL; Chebotareva NV; Nikogosova AD; Demyanova KA; Varshavsky VA; Roshchupkina SV
    Ter Arkh; 2016; 88(6):77-79. PubMed ID: 27296266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why has plasma exchange failed in TRACK syndrome? Lessons from a new variant of the atypical hemolytic uremic syndrome.
    Durak C; Sahin EG; Yusuf Can Y; Varol F; Cam H
    J Clin Apher; 2023 Oct; 38(5):647-650. PubMed ID: 37338178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
    Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP
    Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Atypical hemolytic uremic syndrome].
    Sepúlveda RA; Tagle R; Jara A
    Rev Med Chil; 2018 Jun; 146(6):770-779. PubMed ID: 30148909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.
    Provaznikova D; Rittich S; Malina M; Seeman T; Marinov I; Riedl M; Hrachovinova I
    Pediatr Nephrol; 2012 Jan; 27(1):73-81. PubMed ID: 21706448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)-Two Diseases That Exacerbate Each Other: Case Report.
    Bogdał A; Badeński A; Pac M; Wójcicka A; Badeńska M; Didyk A; Trembecka-Dubel E; Dąbrowska-Leonik N; Walaszczyk M; Matysiak N; Morawiec-Knysak A; Szczepański T; Szczepańska M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case report - atypical hemolytic uremic syndrome triggered by influenza B.
    Kobbe R; Schild R; Christner M; Oh J; Loos S; Kemper MJ
    BMC Nephrol; 2017 Mar; 18(1):96. PubMed ID: 28320387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
    Kistler AD
    Praxis (Bern 1994); 2016 Mar; 105(7):389-96. PubMed ID: 27005733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 'silent', new polymorphism of factor H and apparent de novo atypical haemolytic uraemic syndrome after kidney transplantation.
    Broeders EN; Stordeur P; Rorive S; Dahan K
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25538218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
    Ono M; Ohashi N; Namikawa A; Katahashi N; Ishigaki S; Tsuji N; Isobe S; Iwakura T; Sakao Y; Tsuji T; Kato A; Fujigaki Y; Shimizu A; Yasuda H
    Intern Med; 2018 Jun; 57(11):1617-1623. PubMed ID: 29434134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxymorphone Induced Thrombotic Microangiopathy Mimicking Atypical Haemolytic Uremic Syndrome.
    Gandhi A; Ullah S; Kotadia S; Nasser S
    J Ayub Med Coll Abbottabad; 2017; 29(2):360-362. PubMed ID: 28718268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemolytic uremic syndrome with multiple organ involvement secondary to complement factor H p.Arg1215X mutation.
    Yeşilbaş O; Şevketoğlu E; Petmezci MT; Kıhtır HS; Benzer M; Berdeli A
    Turk J Pediatr; 2017; 59(5):576-580. PubMed ID: 29745120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant.
    Pinte L; Sorohan BM; Prohászka Z; Gherghiceanu M; Băicuş C
    Rom J Intern Med; 2022 Jun; 60(2):138-142. PubMed ID: 34997957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.